Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- North Melbourne
- Most recent report
- 6-K, filed Sep 2, 2026
- Filings on record
- 100 filings
- On EDGAR
- CIK 2007191
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 60
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 1, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 20, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 21, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 2, 2026
- 6-K Report a foreign issuer made public elsewhere May 21, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 23, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 21, 2026
Prospectuses and Registrations 2
Ownership 8 of 14
- 3 Insider reported their initial holding May 18, 2026
- 3 Insider reported their initial holding May 18, 2026
- 3 Insider reported their initial holding May 18, 2026
- 4 Insider reported a trade May 6, 2026
- 4 Insider reported a trade Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
Other 8 of 24
- 20-F/A Annual report, foreign issuer, amended Mar 20, 2026
- F-3ASR Feb 20, 2026
- SEC STAFF LETTER Nov 21, 2024
- EFFECT Notice that a registration became effective Nov 12, 2024
- SEC STAFF ACTION Nov 12, 2024
- CERT Exchange certified a listing Nov 12, 2024
- CORRESP Reply to SEC staff Nov 12, 2024
- 20FR12B/A Amended filing Oct 30, 2024
Everything here comes from Telix Pharmaceuticals Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.